DynaMed
DynaMed, an EBSCO Clinical Decisions product, is an evidence-based clinical decision support platform serving physicians, nurses, and healthcare institutions. It provides point-of-care medical information, specialty content, drug resources, and AI-assisted decision support via institutional subscriptions.
- Company typePrivate
- Founded-
- HeadquartersIpswich, United States
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What DynaMed does
DynaMed is an evidence-based clinical decision support (CDS) platform operated as a product brand by EBSCO Clinical Decisions, a division of the privately held EBSCO Industries conglomerate. The platform is designed to give physicians, nurses, and other healthcare professionals rapid point-of-care access to synthesized medical evidence, specialty-specific clinical content, drug reference information, chemotherapy regimen protocols, clinical calculators, alerts, and patient education materials. As of January 2026, DynaMed added an exclusive licensing arrangement with the New England Journal of Medicine that gives it same-day access to select NEJM article summaries — a right no other CDS vendor holds — and operates Dyna AI, an AI-augmented clinical decision support module layered on top of the core evidence corpus.
Under the hood, DynaMed is a web-based software-as-a-service platform extended to iOS and Android mobile apps, with text-based knowledge retrieval and synthesis across a curated, continuously updated evidence corpus organized by medical specialty. The technology stack combines editorial curation with AI-assisted retrieval (Dyna AI) and integrates drug databases, clinical calculators, and alert workflows into a unified point-of-care interface. Content licensing — particularly the NEJM same-day feed — is the platform's primary content differentiator.
DynaMed makes money through annual institutional subscriptions sold directly to healthcare organizations, hospitals, and health systems via an enterprise field sales motion. Pricing is quote-based and not publicly disclosed, with no individual consumer or per-seat self-serve offering. The company is headquartered in Ipswich, Massachusetts, employs 101–250 people, and distributes globally via web and mobile channels under the EBSCO Health umbrella. Customer concentration, revenue figures, and headcount trend data are not disclosed in the available input.
DynaMed firmographics
Firmographics- Name
- DynaMed
- Legal name
- EBSCO Industries, Inc.
- Website
- https://dynamed.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DynaMed, an EBSCO Clinical Decisions product, is an evidence-based clinical decision support platform serving physicians, nurses, and healthcare institutions. It provides point-of-care medical information, specialty content, drug resources, and AI-assisted decision support via institutional subscriptions.
- Ownership category
- akta.pro rank
Where DynaMed is headquartered
LocationHeadquarters
- HQ city
- Ipswich
- HQ country
- United States
- HQ region
- North America
Markets served
DynaMed business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Revenue model
- Subscription Licensing: DynaMed operates as a subscription-based clinical decision support solution sold to healthcare organizations, hospitals, and health systems. The platform is offered as a licensed service to enterprise customers in the healthcare sector.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Institutional subscription for healthcare organizations |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
DynaMed product offering
Product offeringCore offering
DynaMed is a web-based, subscription clinical decision support platform that provides clinicians with evidence-based medical information, diagnostic guidance, treatment recommendations, drug references, specialty-specific content, and clinical calculators at the point of care. The platform integrates AI-powered reasoning through Dyna AI and offers exclusive same-day access to New England Journal of Medicine article summaries, helping healthcare professionals reduce time spent searching clinical evidence and improve diagnostic accuracy.
Product overview
DynaMed is a unified evidence-based clinical decision support platform offered by EBSCO Clinical Decisions. The core DynaMed platform integrates specialty-specific clinical content, drug resources, chemotherapy regimens, patient information, clinical calculators, and alerts. Dyna AI serves as an AI-powered enhancement module within the platform. The product portfolio includes specialized content modules for drug resources, chemo regimens, patient education, and medical calculators, all accessible via web and mobile platforms.
Differentiator
Problem solved
Functional benefit
Brands
- Dyna AI: AI-powered feature within DynaMed for clinical decision support and documentation assistance.
Products and services
- DynaMed Evidence-based clinical decision support platform providing point-of-care medical information, diagnostic guidance, treatment recommendations, drug references, specialty-specific content, clinical calculators, and alerts to clinicians. Sold via institutional subscription to hospitals, health systems, and healthcare organizations.
- Dyna AI AI-powered clinical decision support module integrated within the DynaMed platform, enhancing clinical reasoning and diagnostic assistance through artificial intelligence capabilities. Targeted at healthcare organizations subscribing to DynaMed.
- NEJM Same-Day Access Feature within the DynaMed platform providing exclusive same-day access to summaries of select New England Journal of Medicine articles, available the day the NEJM embargo is lifted. Available to subscribing healthcare institutions.
Quantifiable outcome
- 75% of clinicians save four or more minutes per patient encounter with AI-CDS tools
- +2 more outcomes
Companies that use DynaMed
Customer profileSegments2 records
Ideal customer profiles1 record
DynaMed technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
DynaMed partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- New England Journal of Medicine (NEJM)coreDynaMed holds an exclusive licensing agreement with NEJM to provide same-day access to select New England Journal of Medicine article summaries within the DynaMed clinical decision support platform. This is a unique differentiator as DynaMed is the only CDS solution with licensed rights to same-day NEJM access. Summaries appear on the homepage and within relevant clinical topics on the same day the NEJM embargo is lifted.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
DynaMed competitors and assessment
Company assessmentEmerging players
- Isabel Healthcare: Isabel is a differential diagnosis decision support tool used by clinicians and hospitals, overlapping with DynaMed's diagnostic reasoning use case but with a narrower scope.
- OpenEvidence: OpenEvidence is an AI-native clinical evidence platform surfacing medical literature answers to clinician questions, representing a newer entrant challenging traditional curated CDS tools like DynaMed.
Direct peers
- Epocrates: Epocrates is a clinical reference app used by physicians for drug lookup, interaction checking, and point-of-care guidance, overlapping with DynaMed's clinician-facing drug resources and reference use cases.
- BMJ Best Practice: BMJ Best Practice is an evidence-based point-of-care clinical decision support tool used by clinicians worldwide, offering comparable specialty content, treatment guidance, and institutional licensing similar to DynaMed.
- UpToDate: Wolters Kluwer's UpToDate is the dominant evidence-based clinical decision support platform for hospitals and clinicians, with deep EHR integration and the largest installed base in the category DynaMed competes in.
- ClinicalKey: Elsevier's ClinicalKey is a clinician reference and decision support platform combining medical content, drug information, and point-of-care guidance, directly competing with DynaMed in hospital and health system subscriptions.
- VisualDx: VisualDx is a visual clinical decision support system used by clinicians to aid diagnosis and differential diagnosis at the point of care, competing in the same institutional CDS purchase as DynaMed.
- Micromedex: Merative's Micromedex is a clinical reference suite covering drug information, toxicology, and disease content, widely licensed to hospitals alongside or in competition with DynaMed's drug and clinical reference modules.
- Lexicomp: Wolters Kluwer's Lexicomp is a leading institutional drug information and clinical reference solution sold to hospitals and health systems, overlapping with DynaMed's drug resources and clinical decision support modules.
Broad incumbents
- Wolters Kluwer Health (Clinical Solutions portfolio): Wolters Kluwer's clinical solutions division bundles UpToDate, Lexicomp, and Medi-Span, providing the broadest incumbent portfolio competing against EBSCO Clinical Decisions and DynaMed across drug, evidence, and CDS categories.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat5 records
Key highlights6 records
Customer concentration
DynaMed social profiles
Digital presenceDynaMed financial estimates
Financial estimateRevenue estimate
Valuation estimate
DynaMed leadership team
Management profileNumber of profiles
Profiles1 record
DynaMed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DynaMed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DynaMed
What does DynaMed do?
DynaMed is a web-based, subscription clinical decision support platform that provides clinicians with evidence-based medical information, diagnostic guidance, treatment recommendations, drug references, specialty-specific content, and clinical calculators at the point of care. The platform integrates AI-powered reasoning through Dyna AI and offers exclusive same-day access to New England Journal of Medicine article summaries, helping healthcare professionals reduce time spent searching clinical evidence and improve diagnostic accuracy.
Is DynaMed a public or private company?
DynaMed is a private company. It is classified as corporate owned and is currently operating.
When was DynaMed founded?
DynaMed was founded in -1. It employs 101 to 250 people.
Where is DynaMed based?
DynaMed is headquartered in Ipswich, United States, in the North America region.
How does DynaMed make money?
One revenue line is on record: subscription Licensing.
Who are DynaMed's main competitors?
Emerging players on record are Isabel Healthcare and OpenEvidence. Direct peers are Epocrates, BMJ Best Practice, UpToDate, ClinicalKey, VisualDx, Micromedex and Lexicomp. Wolters Kluwer Health (Clinical Solutions portfolio) is listed as a broad incumbent.
Does DynaMed have an API?
No public API is recorded for DynaMed.